Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers

Biochemical Pharmacology

Volumn 66, Issue 8, 2003, Pages 1651-1659

  Piette, Jacques ^a   Volanti, Cédric ^a   Vantieghem, Annelies ^b   Matroule, Jean Yves ^a   Habraken, Yvette ^a   Agostinis, Patrizia ^b  

^a UNIVERSITY OF LIÈGE   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Apoptosis; Bcl 2; Mitochondria; Photodynamic therapy; Photosensitizer

Indexed keywords

CASPASE; CASPASE 9; DNA; HYPERICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOTOSENSITIZING AGENT; PROTEIN BCL 2; PYROPHEOBRIDE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; DRUG DERIVATIVE; PERYLENE;

APOPTOSIS; CANCER CELL; CELL CYCLE G2 PHASE; CELL DEATH; CELL GROWTH; COLON CARCINOMA; CONFERENCE PAPER; DNA DETERMINATION; DRUG DISTRIBUTION; DRUG MECHANISM; DRUG MEGADOSE; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; FLOW CYTOMETRY; HUMAN; INTRACELLULAR SPACE; LOW DRUG DOSE; LYSOSOME; MITOCHONDRION; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; WESTERN BLOTTING; ANIMAL; CELL DIVISION; DRUG EFFECT; METABOLISM; NEOPLASM; PHOTOCHEMOTHERAPY; REVIEW;

ANIMALS; APOPTOSIS; CELL DIVISION; HUMANS; MITOCHONDRIA; NEOPLASMS; PERYLENE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PROTO-ONCOGENE PROTEINS C-BCL-2; REACTIVE OXYGEN SPECIES;

EID: 0642345193     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(03)00539-2     Document Type: Conference Paper

References (38)

1. Wilson B.C. Photodynamic therapy for cancer: principles. Can. J. Gastroenterol. 16:2002;393-396.
2. Hopper C. Photodynamic therapy: a clinical reality in the treatment of cancer. Lancet Oncol. 1:2000;212-219.
3. Rechtman E., Ciulla T.A., Criswell M.H., Pollack A., Harris A. An update on photodynamic therapy in age-related macular degeneration. Expert Opin. Pharmacother. 3:2002;931-938.
4. Niedre M., Patterson M.S., Wilson B.C. Direct near-infrared luminescence detection of singlet oxygen generated by photodynamic therapy in cells in vitro and tissues in vivo. Photochem. Photobiol. 75:2002;382-391.
5. Girotti A.W. Lipid hydroperoxide generation, turnover, and effector action in biological systems. J. Lipid Res. 39:1998;1529-1542.
6. Wright A., Bubb W.A., Hawkins C.L., Davies M.J. Singlet oxygen-mediated protein oxidation: evidence for the formation of reactive side chain peroxides on tyrosine residues. Photochem. Photobiol. 76:2002;35-46.
7. Ravanat J.L., Di Mascio P., Martinez G.R., Medeiros M.H., Cadet J. Singlet oxygen induces oxidation of cellular DNA. J. Biol. Chem. 275:2000;40601-40604.
8. Sharman W.M., Allen C.M., Van Lier J.E. Photodynamic therapeutics: basic principles and clinical applications. DDT. 4:1999;507-517.
9. Agostinis P., Vantieghem A., Merlevede W., de Witte P.A. Hypericin in cancer treatment: more light on the way. Int. J. Biochem. Cell Biol. 34:2002;221-241.
10. Morton C.A. The emerging role of 5-ALA-PDT in dermatology: is PDT superior to standard treatments? J. Dermatolog. Treat. 13(Suppl. 1):2002;S25-S29.
11. Jeffes E.W. Levulan: the first approved topical photosensitizer for the treatment of actinic keratosis. J. Dermatolog. Treat. 13(Suppl. 1):2002;S19-S23.
12. Oleinick N.O., Morris R.L., Belichenko The role of apoptosis in response to photodynamic therapy: what, where, why and how. Photochem. Photobiol. Sci. 1:2002;1-21.
13. Cecic I., Korbelik M. Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors. Cancer Lett. 183:2002;43-51.
14. Granville D.J., McManus B.M., Hunt D.W. Photodynamic therapy: shedding light on the biochemical pathways regulating porphyrin-mediated cell death. Histol. Histopathol. 16:2001;309-317.
15. Klotz L.O., Fritsch C., Briviba K., Tsacmacidis M., Schliess F., Sies H. Activation of JNK and p38 but not ERK MAP kinases in human skin cells by 5-aminolevulinate-photodynamic therapy. Cancer Res. 58:1998;4297-4300.
16. Vermes I., Haanen C., Steffens-Nakken H., Reutelingsperger C. A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labeled annexin V. J. Immunol. Methods. 184:1995;39-51.
17. Chiu S., Evans H.H., Lam M., Nieminen A., Oleinick N.L. Phthalocyanine 4 photodynamic therapy-induced apoptosis of mouse L5178Y-R cells results from a delayed but extensive release of cytochrome c from mitochondria. Cancer Lett. 165:2001;51-58.
18. Reiners J.J. Jr., Caruso J.A., Mathieu P., Chelladurai B., Yin X.M., Kessel D. Release of cytochrome c and activation of pro-caspase-9 following lysosomal photodamage involves Bid cleavage. Cell Death Differ. 9:2002;934-944.
19. Li Q., Verma I.M. NF-kappaB regulation in the immune system. Nat. Rev. Immunol. 2:2002;725-734.
20. Amit S., Ben-Neriah Y. NF-kappaB activation in cancer: a challenge for ubiquitination- and proteasome-based therapeutic approach. Semin. Cancer Biol. 13:2003;15-28.
21. Ghosh S., Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 109:2002;S81-S96.
22. Matroule J.Y., Bonizzi G., Morliere P., Paillous N., Santus R., Bours V., Piette J. Pyropheophorbide - a methyl ester-mediated photosensitization activates transcription factor NF-kappaB through the interleukin-1 receptor-dependent signaling pathway. J. Biol. Chem. 274:1999;2988-3000.
23. Li X., Massa P.E., Hanidu A., Peet G.W., Aro P., Savitt A., Mische S., Li J., Marcu K.B. IKKalpha, IKKbeta, and NEMO/IKKgamma are each required for the NF-kappa B-mediated inflammatory response program. J. Biol. Chem. 277:2002;45129-45140.
24. Matroule J.Y., Carthy C.M., Granville D.J., Jolois O., Hunt D.W., Piette J. Mechanism of colon cancer cell apoptosis mediated by pyropheophorbide - a methylester photosensitization. Oncogene. 20:2000;4070-4084.
25. Vantieghem A., Assefa Z., Vandenabeele P., Declercq W., Courtois S., Vandenheede J.R., Merlevede W., de Witte P., Agostinis P. Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis. FEBS Lett. 440:1998;19-24.
26. Assefa Z., Vantieghem A., Declercq W., Vandenabeele P., Vandenheede J.R., Merlevede W., de Witte P., Agostinis P. The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin. J. Biol. Chem. 274:1999;8788-8796.
27. Vantieghem A., Xu Y., Declercq W., Vandenabeele P., Denecker G., Vandenheede J.R., Merlevede W., de Witte P.A., Agostinis P. Different pathways mediate cytochrome c release after photodynamic therapy with hypericin. Photochem. Photobiol. 74:2001;133-142.
28. 2/M phase-arrested cells following photodynamic therapy with hypericin involves a CDK1-mediated signal and delays the onset of apoptosis. J. Biol. Chem. 277:2002;37718-37731.
29. Fadeel B., Zhivotovsky B., Orrenius S. All along the watchtower: on the regulation of apoptosis regulators. FASEB J. 13:1999;1647-1657.
30. Kim H.R., Luo Y., Li G., Kessel D. Enhanced apoptotic response to photodynamic therapy after bcl-2 transfection. Cancer Res. 59:1999;3429-3432.
31. Kessel D., Castelli M. Evidence that bcl-2 is the target of three photosensitizers that induce a rapid apoptotic response. Photochem. Photobiol. 74:2001;318-322.
32. Xue L.Y., Chiu S.M., Oleinick N.L. Photochemical destruction of the Bcl-2 oncoprotein during photodynamic therapy with the phthalocyanine photosensitizer Pc 4. Oncogene. 20:2001;3420-3427.
33. Pathan N., Aime-Sempe C., Kitada S., Basu A., Haldar S., Reed J.C. Microtubule-targeting drugs induce bcl-2 phosphorylation and association with Pin1. Neoplasia. 3:2001;550-559.
34. Blagosklonny M.V. Unwinding the loop of Bcl-2 phosphorylation. Leukemia. 15:2001;869-874.
35. Ruvolo P.P., Deng X., May W.S. Phosphorylation of Bcl2 and regulation of apoptosis. Leukemia. 15:2001;515-522.
36. Deng X., Xiao L., Lang W., Gao F., Ruvolo P., May W.S. Jr. Novel role for JNK as a stress-activated Bcl2 kinase. J. Biol. Chem. 276:2001;23681-23688.
37. Yamamoto K., Ichijo H., Korsmeyer S.J. BCL-2 is phosphorylated and inactivated by an ASK1/Jun N-terminal protein kinase pathway normally activated at G(2)/M. Mol. Cell Biol. 19:1999;8469-8478.
38. Haldar S., Basu A., Croce C.M. Serine-70 is one of the critical sites for drug-induced Bcl2 phosphorylation in cancer cells. Cancer Res. 58:1998;1609-1615.